Value of the concept of minimal detectable dosage in human hair.
The influence on drug incorporation of melanin affinity, lipophilicity, and membrane permeability is of paramount importance. Despite their high lipophilicity, some drugs have quite low incorporation rate into hair, suggesting that the higher incorporation rates of basic drugs (cocaine, amphetamines.) than neutral (steroids, benzodiazepines, cannabinoids…) or acidic ones are strongly related to the penetrating ability of the drug to break through the membrane based on the pH gradient between blood and the acidic hair matrix. When using hair analysis as a matrix during investigative analysis, e.g. workplace drug testing, doping, driving under the influence, drug-facilitated crime, the question of importance is to know whether the analytical procedure was sensitive enough to identify traces of drugs; this is particularly important when the urine sample(s) of the subject was positive and the hair sample(s) was negative. It has been accepted in the forensic community that a negative hair result cannot exclude the administration of a particular drug, or one of its precursors and the negative findings should not overrule a positive urine result. Nevertheless, the negative hair findings can, on occasion, cast doubt on the positive urine analysis, resulting in substantial legal debate and various consequences for the subject. The concept of minimal detectable dosage in hair is of interest to document the negative findings, but limited data is currently available in the scientific literature. Such data includes cocaine, codeine, ketamine, some benzodiazepines and some unusual compounds. Until laboratories will have sensitive enough methodologies to detect a single use of drug, care should be taken to compare urine and hair findings.
X-Pertise Consulting, 84 route de Saverne, 67205 Oberhausbergen, France. pkintz@x-pertise.com
Pascal
P
Kintz
D053593:Forensic Toxicology; D006197:Hair / Q000737:chemistry*; D006801:Humans; D057230:Limit of Detection; D009294:Narcotics / Q000008:administration & dosage* / Q000032:analysis; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000032:analysis; D015813:Substance Abuse Detection / Q000379:methods
D009294:Narcotics; D004364:Pharmaceutical Preparations